🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall objective of this study was to assess the efficacy and safety o...
Status
Completed
Location
Pearl Investigative Site
Start Date
2015-01-28
Trial ID
NCT03256552
This is a multi-center, randomized, double-blind, parallel group, chronic d...
Status
Completed
Location
Pearl Investigative Site
Start Date
2013-11
Trial ID
NCT01970878
To assess the effect of treatment with Glycopyronnium (GP) MDI administered...
Status
Completed
Location
Research Site
Start Date
2016-12-29
Trial ID
NCT02937584
Treatments Being Tested
Study Comparing the Efficacy and Safety of PT001 to Placebo and Open-label ...
Status
Completed
Location
Research Site
Start Date
2017-12-13
Trial ID
NCT03358147
Treatments Being Tested
A Randomized, Double-Blind, Single-Dose, Four-Period, Four-Treatment, Cross...
Status
Completed
Location
SNBL
Start Date
2014-07
Trial ID
NCT02196714
This is a multicenter, randomized, double-blind, parallel group, chronic-do...
Status
Completed
Location
Pearl Investigative Site
Start Date
2013-07
Trial ID
NCT01854658
Treatments Being Tested
A Randomized, Double-Blind, Chronic Dosing (14 days), 5-Period, 7-Treatment...
Status
Completed
Location
Pearl Therapeutics Inc.
Start Date
2015-05-27
Trial ID
NCT02433834
Treatments Being Tested
A chronic dosing (24 weeks) study to assess the efficacy and safety GFF MDI...
Status
Completed
Location
Research Site
Start Date
2015-03-30
Trial ID
NCT02343458
Treatments Being Tested
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
Pearl Investigative Site
Start Date
2013-05
Trial ID
NCT01854645